Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2017

Nov 14, 2017

SELL
$55.23 - $63.74 $13.2 Million - $15.3 Million
-239,358 Closed
0 $0
Q2 2017

Aug 15, 2017

BUY
N/A
239,358
239,358 $13.3 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Atlanta Capital Management CO L L C Portfolio

Follow Atlanta Capital Management CO L L C and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlanta Capital Management CO L L C, based on Form 13F filings with the SEC.

News

Stay updated on Atlanta Capital Management CO L L C with notifications on news.